Jacob E. Koskimaki

Peptides Derived from Type IV Collagen, CXC Chemokines, and Thrombospondin-1 Domain-Containing Proteins Inhibit Neovascularization and Suppress Tumor Growth in MDA-MB-231 Breast Cancer Xenografts

Jacob E. Koskimaki, Emmanouil D. Karagiannis, Elena Roşca et al. · Neoplasia · 2009 · 67 citations · Full text

Medicine, Oncology, Pharmacology +12

Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide

Ron B. Shmueli, Masayuki Ohnaka, Akiko Miki et al. · Biomaterials · 2013 · 57 citations · Full text

Pharmacy, Ophthalmology, Pharmaceutics +16

Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health Record Systems to Support Improved Quality of Care

Danielle Potter, Raven Brothers, Andrej Kolacevski et al. · JCO Clinical Cancer Informatics · 2020 · 55 citations · Full text

Computing, Health Informatics, Oncology +9

Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model

Jacob E. Koskimaki, Emmanouil D. Karagiannis, Benjamin C. Tang et al. · BMC Cancer · 2010 · 54 citations · Full text

Medicine, Bioinformatics, Oncology +15

Inhibition of Lymphangiogenesis and Angiogenesis in Breast Tumor Xenografts and Lymph Nodes by a Peptide Derived from Transmembrane Protein 45A

Esak Lee, Jacob E. Koskimaki, Niranjan B. Pandey et al. · Neoplasia · 2013 · 52 citations · Full text

Medicine, Oncology, Pharmacology +17